CUMBERLAND - (BUSINESS WIRE) Peak Harvest Health, a Maryland-based medical cannabis manufacturing company pursuing a cultivation license from the Natalie M. LaPrade Maryland Medical Cannabis Commission, today announced plans to partner with Western Maryland Health System to offer qualified patients medical cannabis to treat pain, cancer, multiple sclerosis, post-traumatic stress disorder and other conditions in accordance to state regulations.
WMHS last year diagnosed more than 2,200 patients with diseases that could potentially be treated with medical cannabis under Maryland law, sparking its interest in how this newly available medication could serve their patient population.
“Providing safe and effective medicine to patients that need it is PHH’s number one priority, and partnering with WMHS will help us quickly reach people in the most need,” said Ethan Ruby, CEO of PHH. “With a focus on patient-centered care and improving the health and well-being of people in the communities they serve, WMHS is a perfect partner for PHH, and we look forward to working closely with their more than 400 physicians and healthcare professionals to provide the best possible care for their patients.”
Together WMHS and PHH hope to collaborate on research to advance the science of medical cannabis, with a goal of producing the most effective formulations for future use.
They also will create an educational plan for doctors, healthcare providers, patients and caregivers for the use of medical cannabis; and develop patient studies to track health outcomes and costs associated with the use of medical cannabis, including, but not limited to, the reduction of opioid use, abuse and dependence.
“Partnering with PHH was not a decision we considered lightly. But after research and extensive discussions with the company, it was clear that their experience producing medical cannabis medicine in other highly regulated markets made PHH the perfect partner to help us provide our patients access to safe and effective medicine,” said Barry Ronan, CEO of WMHS. “Maryland’s tightly regulated access to medical cannabis will provide a critical alternative to prescription painkillers, such as opioids, which, because of their addictiveness, have ravaged many communities across Maryland and throughout the U.S. Last year alone, we diagnosed 1,135 episodes of opioid dependence, abuse or overdose. Too many families experience pain and suffering at the hands of this opioid epidemic, and deserve a safer, more effective treatment option.”
In November 2015, PHH applied for one of the up to 15 medical cannabis cultivation licenses expected to be awarded by the Natalie M. LaPrade Maryland Medical Cannabis Commission in 2016.
PHH has committed to locating its production and processing operations in Cumberland, Md., at the Riverside Industrial Park, and in August, the company received unanimous approval from the Mayor of Cumberland and City Council to support the company’s application.
PHH projects that up to 35 new jobs will be created in Cumberland during its first year of operation, and more than 100 new jobs by 2020.
About Western Maryland Health System
The Western Maryland Health System in Cumberland provides a comprehensive range of healthcare services along the continuum of care for residents in Allegany and Garrett Counties in Maryland and surrounding counties in West Virginia and Pennsylvania.
WMHS includes the Western Maryland Regional Medical Center, a 275-bed facility that opened in November 2009. Other facets of WMHS include a nursing home, outpatient diagnostic centers and a network of urgent care clinics, primary care centers and physician practices.
About Peak Harvest Health
Peak Harvest Health is a Maryland-based pharmaceutical manufacturing company pursuing a medical cannabis cultivation license from the state of Maryland.
Dedicated to improving the lives of Maryland’s qualifying patients and advancing the overall science of the medical cannabis industry, PHH’s team has extensive experience in medical cannabis production and processing in some of the nation’s most highly regulated markets, as well as in healthcare, business operational management and, real estate development and finance.